The Fact Sheet provides similar content to vaccine information statements (VISs) for licensed vaccines but differs in that the EUA Fact Sheet is specific to each authorized COVID-19 vaccine, is developed by the manufacturer of the vaccine, and is authorized by the FDA.
JAB
Show more
See More
Mar 04, 2022 . Vaccine Information Statements (VISs) are information sheets produced by the Centers for Disease Control and Prevention (CDC). VISs explain both the benefits and risks of a vaccine to adult vaccine recipients and the parents or legal representatives of. vaccinees who are children and adolescents. Federal law requires that VISs be handed out ...
Show more
See More
Sheet for the authorized Moderna COVID-19 Vaccine and also includes information about the FDA-licensed vaccine, SPIKEVAX (COVID-19 Vaccine, …
Show more
See More
The history of JAB dates back to the early 19th Century, when predecessors of the Reimann family established Benckiser, a chemical and industrial manufacturing company based in Germany. During the early part of the 20th century, Benckiser was a small to medium sized business, primarily a supplier to the food industry, and its main products ...
Show more
See More
This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine for use in …
Show more
See More
Mar 29, 2022 . Comirnaty Information Pfizer-BioNTech Fact Sheets Pfizer-BioNTech Fact Sheet Translations Información sobre las vacunas para el COVID-19 On August 23, 2021, FDA announced the first approval of a ...
Show more
See More
COVID-19 vaccination – After your Vaxzevria (AstraZeneca) vaccine. 5 March 2021. Fact sheet. Patient information sheet on AstraZeneca COVID-19 vaccine and thrombosis with thrombocytopenia syndrome (TTS) 10 April 2021. Fact sheet. COVID-19 vaccination – Weighing up the potential benefits against risk of harm from COVID-19 Vaccine AstraZeneca.
Show more
See More
JAB employs approximately 50 professionals, including 11 partners, who have extensive industry and investment experience. The history of JAB dates back to the early 19th Century, when predecessors of the Reimann family established Benckiser, a chemical and industrial manufacturing company based in Germany.
In 2012, JAB Holding Company was formed as a partner-led investment firm, with the consolidation of all business assets, and its portfolio has expanded to the present day. For more background on the history of Benckiser from the 1920s to the 1940s, please visit the Alfred Landecker Foundation website.
JAB is focused on long-term value creation by investing in companies with premium brands, attractive growth and strong cash flow, and has controlling and anchor stakes in companies across the following five Investment Platforms: JAB has investment offices in Washington D.C., London, Amsterdam, São Paulo, Luxembourg and Mannheim.
To access the most recent Fact Sheets, please scan the QR code provided below. Global website Telephone number www.cvdvaccine.com 1-877- 829 -2619 (1-877- VAX- CO19) 6 Revised: 29 October 2021